Egbert Bakker

Accurate proteome-wide missense variant effect prediction with AlphaMissense

The promise and challenge of therapeutic genome editing

Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients

Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family